Home › Funds › NAN FUNG TRINITY (HK) Ltd › MIRM

NAN FUNG TRINITY (HK) Ltd position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

NAN FUNG TRINITY (HK) Ltd reported holding 222,679 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$19.0M, representing 1.83% of its reported portfolio and ranking #21 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed MIRM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)222.68K sh
Reported value held$19.03M
Portfolio Weight1.83%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NAN FUNG TRINITY (HK) Ltd's MIRM position evolved

NAN FUNG TRINITY (HK) Ltd first disclosed a stake in MIRM in Q2 2025 at 146,765 shares (US$7.5M). The position peaked in Q2 2026 at 232,679 shares, worth US$27.2M. Across 6 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 222,679 shares valued at US$19.0M — a reduction of -10,000 shares quarter over quarter.. Notable position changes include a 46% increase in Q4 2025 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 146.76K $7.47M New
Q3 2025 156.26K $11.46M Add
Q4 2025 227.48K $17.97M Add
Q1 2026 232.68K $21.49M Add
Q2 2026 232.68K $27.24M Hold
Q3 2026 222.68K $19.03M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has NAN FUNG TRINITY (HK) Ltd held MIRM?

NAN FUNG TRINITY (HK) Ltd has disclosed MIRM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is NAN FUNG TRINITY (HK) Ltd's current position in MIRM?

As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 222.68K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $19.03M, representing 1.83% of its reported portfolio and ranking #21.

Has NAN FUNG TRINITY (HK) Ltd been buying or selling MIRM?

In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd reduced its position in MIRM. The position peaked in Q2 2026 at 232.68K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.